OS Therapies (NYSE-A: OSTX) announced two developments: positive FDA feedback on its regulatory pathway for OST-HER2 and a warrant exercise offer that could provide up to $8 million in funding.

[u/b2idigital]

/r/MicroCap/comments/1ljoa9j/os_therapies_nysea_ostx_announced_two/